Jump to content

Bruce A. Sullenger

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rcdubois (talk | contribs) at 18:41, 28 September 2018. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Bruce Alan Sullenger, Ph.D. is the Joseph W. and Dorothy W. Beard Professor of Experimental Surgery at the Duke University School of Medicine, the Founding Director of the Duke Translational Research Institute (DTRI) which he led from 2006-2016, and the Associate Director for Translation in the Duke Cancer Institute (DCI).[1][2]

Education and Previous Appointments

Sullenger obtained his B.S. in Biology from Indiana University and his Ph.D. in Molecular Biology from Cornell University and Memorial Sloan-Kettering Cancer Center.  He performed postdoctoral studies in Thomas Cech’s laboratory in the Department of Biochemistry at the University of Colorado.[3] Since coming to Duke University in 1994, he has held positions in the Departments of Surgery, Molecular Genetics and Microbiology, and Pharmacology and Cancer Biology.[4]

Scientific Contributions

Sullenger runs the Duke Cardiovascular Biology Laboratory and serves as the scientific director of the affiliated Duke Translational Medicine Institute (DTMI) Translational Research Center for Thrombotic and Hemostatic Disorders. His research focus is developing RNA-based therapeutic agents, which may potentially be used as treatments for a wide range of diseases from cardiovascular and inflammatory diseases to cancer and stroke.[3] His research program is actively exploring the translation of the molecular therapeutics invented in his laboratory into the clinical setting.[5]

Professional Memberships and Awards

Sullenger is Co-Editor-in-Chief of Nucleic Acid Therapeutics,[6] the official journal of the Oligonucleotide Therapeutics Society, and serves on the editorial board of Molecular Therapy, the official journal of the American Society of Gene and Cell Therapy. Sullenger is a member of a number of professional societies and has received a number of prestigious awards, a selection of which are listed below.

Societies

  • 1995-Present: The RNA Society
  • 1997-Present: American Society of Gene and Cell Therapy, (Board of Directors, 2013-2016)
  • 2005-Present: Oligonucleotide Therapeutics Society, (Board of Directors, 2007-2014, Treasurer, 2008-2010)
  • 2005-Present: American Chemical Society
  • 2005-Present: International Society of Thrombosis and Hemostasis
  • 2006-Present: American Heart Association

Honors and Awards[3]

  • 2000: Awarded the Azure De Ellis Research Award for Sickle Cell Research
  • 2003: Awarded the Joseph W. and Dorothy W. Beard Endowed Chair in Experimental Surgery[1]
  • 2004: Awarded the Ruth & A. Morris Williams, Jr. Faculty Research Prize, Duke University
  • 2008: Elected Board Member and Treasurer of the Oligonucleotide Therapeutics Society
  • 2009: Recipient of the Duke Research Mentoring Award for Translational Research
  • 2010: Recipient of the North Carolina Innovator/Researcher Health Care Heroes Award
  • 2013: Elected to the Board of the American Society of Gene & Cell Therapy (ASGCT)
  • 2014: Elected Fellow of the American Association for the Advancement of Science (AAAS)
  • 2015: Recipient of the Outstanding Achievement Award by the American Society of Gene & Cell Therapy (ASGCT)
  • 2015: Testified about the Importance of Biomedical Research and Innovation for the Nation to the Committee on Health, Education, Labor and Pensions at the United States Senate.
  • 2017: Recipient of the Weill Cornell Graduate School of Medical Sciences Distinguished Alumnus Award[7]

References

  1. ^ a b "Bruce Alan Sullenger, PhD | Duke Department of Surgery". surgery.duke.edu. Retrieved 2018-09-28.
  2. ^ "Bruce Alan Sullenger | Center for Biomolecular and Tissue Engineering". cbte.pratt.duke.edu. Retrieved 2018-09-28.
  3. ^ a b c "Aptamers in Boulder | Bruce A. Sullenger". www.aptamersinboulder.com. Retrieved 2018-09-28.
  4. ^ "Sullenger, Bruce Alan". Duke Cancer Institute. 2016-12-20. Retrieved 2018-09-28.
  5. ^ "Research Laboratories | Duke Department of Surgery". surgery.duke.edu. Retrieved 2018-09-28.
  6. ^ "Nucleic Acid Therapeutics | Mary Ann Liebert, Inc., publishers". home.liebertpub.com. Retrieved 2018-09-28.
  7. ^ "Bruce Sullenger, PhD, Receives Weill Cornell Distinguished Alumnus Award | Duke Department of Surgery". surgery.duke.edu. Retrieved 2018-09-28.